Moreover, IL-10-modified bone marrow mesenchymal stem cells could attenuate the severity of acute graft-versus-host disease after experimental allogeneic stem cell transplantation [22], and IL-10-modified human amniotic mesenchymal stem cells promoted wound healing by exerting multiple synergistic effects [23]. The gene discussed is IL10; the disease is acute graft versus host disease.